Pernille Bjerre Trent: SLN vs LND in Endometrial Cancer
Pernille Bjerre Trent, Senior Consultant at Department of Cancer Surgery at The Norwegian Radium Hospital, shared a post on LinkedIn:
“SLN vs LND in Endometrial Cancer of intermediate (n=333) and high risk (n=663).
- Staging procedures.
- Detection of metastatic nodes.
Results from the sensor study.
Check out our latest paper.”
“Very proud of Pernille Bjerre Trent & our team for the final publication in Pernille’s PhD -Detection of metastatic lymph nodes in women with intermediate- and high-risk endometrial cancer after implementation of SLN.
- SLN-implementation did not compromise detection of stage IIIC disease.
- SLN-implementation led to more patients undergoing nodal assessment as part of surgical staging, ensuring correct allocation into FIGO stage and appropriate adjuvant therapy.
Check our the manuscript.
It’s Open Access in International Journal of Gynecological Cancer (IJGC).”
The detection rate of metastatic lymph nodes comparing sentinel lymph node biopsy and lymphadenectomy for staging of intermediate- and high-risk endometrial carcinoma.
Authors: Pernille Bjerre Trent, Nils Leitzinger, Yun Wang, Gunn Fallås Dahl, Brynhildur Eyjólfsdóttir, Jørgen Fallås Dahl, Kjersti Vassmo Lund, Anne Cathrine Staff, Ragnhild S. Falk, and Ane Gerda Z. Eriksson.
You can read the full article on International Journal of Gynecological Cancer (IJGC).
More posts featuring
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023